Tolleson Wealth Management, Inc. Reata Pharmaceuticals Inc Transaction History

Tolleson Wealth Management, Inc.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	SELL	$79.22 - $105.37 $554,540 - $737,590	-7,000 Reduced 17.39%	33,250 $3.39 Million
Q1 2023 May 15, 2023	SELL	$30.85 - $93.17 $215,950 - $652,190	-7,000 Reduced 14.81%	40,250 $3.66 Million
Q4 2021 Feb 14, 2022	SELL	$25.61 - $110.96 $345,735 - $1.5 Million	-13,500 Reduced 22.22%	47,250 $1.25 Million
Q3 2021 Nov 15, 2021	SELL	$100.0 - $143.02 $2.03 Million - $2.9 Million	-20,250 Reduced 25.0%	60,750 $6.11 Million
Q2 2021 Aug 13, 2021	SELL	$78.27 - $151.29 $2.11 Million - $4.08 Million	-27,000 Reduced 25.0%	81,000 $11.5 Million
Q1 2021 May 05, 2021	BUY	$94.25 - $132.81 $10.2 Million - $14.3 Million	108,000 New	108,000 $10.8 Million

62.7K

Ticker RETA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 31,583,200
Description
Reata Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, identifies, develops, and commercializes novel therapeutics for patients with serious or life-threatening diseases. The company is developing Phase 3 clinical trial programs, including bardoxolone methyl (bardoxolone) for the treatment of patients with chronic kidney diseas...

Get notified when there are updates to the investment portfolio of Tolleson Wealth Management, Inc., based on Form 13F filings with the SEC.

Stay updated on Tolleson Wealth Management, Inc. with notifications on news.